Clinical trial for Osteoarthritis
Official title Ketorolac in Upper Extremity Tendinopathy and Arthropathy
ClinicalTrials.gov ID: NCT05292339
What this study is testing
What is Triamcinolone injection (shoulder, elbow, wrist, or hand)?
An investigational injectable corticosteroid being studied as a potential treatment for osteoarthritis of the shoulder, elbow, wrist, and hand. It is designed to decrease inflammation by inhibiting the release of arachidonic acid from phospholipids.
Also referred to as Triamcinolone.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to find out which injection works better for pain and function in upper arm and hand joint or tendon issues.
- Who it's for
- People with pain or stiffness in their shoulder, elbow, wrist, or hand due to arthritis or tendon problems.
- What's involved
- Participants will receive one injection (either ketorolac or a steroid) and return to the clinic for a check-up 6 weeks later.
- Time commitment
- The study lasts 24 weeks and requires one follow-up visit 6 weeks after the injection.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 or older,
- symptomatic tendinopathy or arthropathy of the shoulder, elbow, hand, or wrist who have not undergone prior surgical treatment for their condition.
- Diagnoses may include trigger finger, De Quervain's tenosynovitis, radiocarpal osteoarthritis, first carpometacarpal (CMC) joint osteoarthritis...
You likely can't join if
- Patients under the age of 18,
- Patients who have undergone prior triamcinolone or ketorolac injections within the past 6 months,
- Patients who have undergone prior surgical treatment for their hand condition,
- Patients with allergy or contraindication to triamcinolone or ketorolac injection,
- Patients with an active infection at the treatment site [active infection defined as cellulitis, purulence, fever, chills, or presence of elevated...
The study team makes the final eligibility decision.
Where it is enrolling
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Atlanta, Georgia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.